On July 12th, Bai Hua Cun Pharma Tech hit the limit up, and Boji Medical Technology, Jinkai Life Science, Shengnuo Biotechnology, Haofan Biotechnology, Porton Pharma Solutions, Sunshine Novartis, and Hebei Changshan Biochemical Pharmaceutical followed the trend. On the news front, Pfizer is advancing the development of a weight loss drug, and the pharmaceutical company is trying to enter the multi-billion dollar weight loss drug market.
A股减肥药概念股走高 百花医药涨停
A-share weight loss drug concept stocks rise, Bai Hua Cun Pharma Tech hits the limit up.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.